Fibroblast GSK-3a Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.

Umbarkar P, Tousif S, Singh AP, Anderson JC, Zhang Q, Tallquist MD, Woodgett J, Lal H. Fibroblast GSK-3a Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart. Circ Res. 2022 09 16; 131(7):620-636.

View in: PubMed

subject areas

Animals
Cardiomyopathies
Collagen
Extracellular Signal-Regulated MAP Kinases
Fibroblasts
Fibrosis
Glycogen Synthase Kinase 3
Heart Failure
MAP Kinase Signaling System
Mice
Mitogen-Activated Protein Kinase Kinases
raf Kinases
Tamoxifen
Transforming Growth Factor beta1

authors with profiles

Michelle Tallquist, PHD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support